Repligen XCell ATF 10 Single-use Device for High Density Cell Culture
Repligen
Details
-
CategoryBioreactor / Fermenter
-
Dimension27.0in x 49.0in x 23.0in
-
SerialLot SA191256
-
Shipping TypeFedEx Ground
-
Manufacturing2019-02-01
-
Voltage / HertzDoes Not Apply / Does Not Apply
Description
The Repligen XCell ATF 10 Single-use Device, manufactured in 2019, is a cutting-edge cell retention device ideal for operations requiring high cell density and viability. Designed to facilitate seamless scaling from XCell ATF 2 to XCell ATF 10, this device is instrumental across various scales of cell culture development and cGMP manufacturing. The device supports bioreactors ranging from 200 to 5000 liters, and features SU and SS formats with a chemistry of PES and PS. Key technical specifications include a typical pore size of 0.2µ for SU and 0.2µ, 0.5µ, 50KDa for SS, an effective filter surface area of 11 m2, and an ATF flow range of 30-80 Lpm. This product remains in pristine, unused condition, housed in its original packaging.
Technician comment
New in unopened box.
Key Features
- Ideal for high cell density and viability
- Supports bioreactors 200-5000L
- Enables scaling from XCell ATF 2 to XCell ATF 10
- SU and SS formats with PES, PS chemistry
- 0.2µ pore size in SU format
- Flow range of 30-80 Lpm
Specifications
- Typical bioreactor size: 200 - 5000 L
- Format: SU, SS
- Chemistry: PES, PS
- Pore size: SU - 0.2µ, SS - 0.2µ, 0.5µ, 50KDa
- Effective surface area: 11 m²
- Filter height: 60 cm
- Displacement volume: 6 L
- ATF flow range: 30 - 80 Lpm
- Scalable flow rate: 12 mL/min/fiber
- Filtrate rate: 4-6 LMH
Weight
Imperial: 90.0 Pounds
Metric: 40.82 Kilograms
Shipping Dimensions
Imperial: 32.4 lb x 58.8 lb x 27.6 lb
Metric: 82.3 cm x 149.35 cm x 70.1 cm
Harmonized Code
902780
Harmonized Code Details
The harmonized code 902780 pertains to instruments and apparatus for physical or chemical analysis which suit the XCell ATF 10's function as a cell retention device in bioprocessing applications.
Comments 0
There are currently no public comments.